BGM
BGM
NASDAQ · Pharmaceuticals

Bgm Group Ltd

$8.27
-0.73 (-8.11%)
As of Nov 7, 2:19 AM ET ·
Financial Highlights (FY 2026)
Revenue
4.46M
Net Income
-2,345,972
Gross Margin
16.6%
Profit Margin
-52.6%
Rev Growth
-16.4%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 16.6% 16.6% 33.1% 33.1%
Operating Margin -33.2% -29.9% 16.8% 14.4%
Profit Margin -52.6% -50.0% 11.7% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.46M 5.33M 106.35M 109.96M
Gross Profit 742.2K 887.5K 35.22M 36.42M
Operating Income -1,479,875 -1,592,785 17.84M 15.80M
Net Income -2,345,972 -2,524,963 12.42M 13.50M
Gross Margin 16.6% 16.6% 33.1% 33.1%
Operating Margin -33.2% -29.9% 16.8% 14.4%
Profit Margin -52.6% -50.0% 11.7% 12.3%
Rev Growth -16.4% -16.4% +7.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 224.9K 224.9K 23.86M 26.94M
Total Equity 54.86M 54.86M 126.32M 122.05M
D/E Ratio 0.00 0.00 0.19 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,308,202 -1,486,237 22.69M 21.79M
Free Cash Flow — — 8.29M 10.61M